FAKTOR OPTIONSSCHEIN - AMGEN | Delayed Deutsche Boerse AG 08:50:45 2024-06-24 EDT | ||
| 10.63 EUR | -2.39% |
|
| Current month | +5.32% | ||
| 1 month | -4.97% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-24 | 10.63 | -2.39% |
| 24-06-21 | 10.89 | +0.37% |
| 24-06-20 | 10.85 | +3.63% |
| 24-06-19 | 10.47 | +0.67% |
| 24-06-18 | 10.4 | +1.86% |
Delayed Quote Deutsche Boerse AG
Last update June 24, 2024 at 08:50 am
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
BNP Paribas
|
| WKN | PH3AMG |
| ISIN | DE000PH3AMG9 |
| Date issued | 2020-02-27 |
| Strike | 308.2 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.68 € |
|---|---|
| Lowest since issue | 4.68 € |
| Spread | 0.18 € |
| Spread % | 1.67% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
308.2
USD
Average target price
316.4
USD
Spread / Average Target
+2.69%
- Stock Market
- Certificates
- Certificat
